ଉଇକିପିଡ଼ିଆ

ବ୍ୟବହାରକାରୀ:Doc James/Test

< ବ୍ୟବହାରକାରୀ:Doc James
Doc James/Test
Clinical data
Pronunciation/pæˈzoʊpənɪb/ paz-OH-pə-nib
Trade namesVotrient
AHFS/Drugs.commonograph
MedlinePlusa610013
data
Pregnancy
category
  • AU: D
  • US: D (Evidence of risk)
Routes of
administration		By mouth (tablets)
Drug classTyrosine kinase inhibitor[୧]
Legal status
Legal status
Pharmacokinetic data
Bioavailability21% (14–39%)[୩]
Protein binding>99.5%[୩][୨]
MetabolismLiver: CYP3A4 (major), 1A2 and 2C8 (minor)[୨]
Elimination half-life30.9±4 hours[୩]
ExcretionFaeces (primary), urine (<4%)[୨]
Identifiers
  • 5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide
Chemical and physical data
FormulaC21H23N7O2S
Molar mass୪୩୭.୫୨ g·mol−1
3D model (JSmol)
  • O=S(=O)(N)c1c(ccc(c1)Nc2nccc(n2)N(c4ccc3c(nn(c3C)C)c4)C)C
  • InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H checkY
  • Key:MQHIQUBXFFAOMK-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Pazopanib, sold under the brand name Votrient, is a medication used to treat renal cell carcinoma (RCC) and certain soft tissue sarcoma.[୪] In RCC it is used when other treatments have failed.[୪] It is taken by mouth.[୪]

Common side effects include diarrhea, high blood pressure, white hair, nausea, tiredness, abdominal pain, low blood cells, and liver problems.[୧] Other side effects may include low thyroid, QT prolongation, bleeding, blood clots, and gastrointestinal perforation.[୧] Use during pregnancy may harm the baby.[୧] It is a tyrosine kinase inhibitor.[୧]

Pazopanib was approved for medical use in the United States in 2009.[୧] In Europe it received conditional approval in 2010 and full approval in 2013.[୫] In the United Kingdom it costs the NHS about £2,250 per month as of 2021.[୪] In the United States this amount costs about 14,200 USD.[୬]

References

ସମ୍ପାଦନା
  1. ↑ ୧.୦ ୧.୧ ୧.୨ ୧.୩ ୧.୪ ୧.୫ ୧.୬ "PAZOPanib Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 4 March 2021. Retrieved 26 October 2021.
  2. ↑ ୨.୦ ୨.୧ ୨.୨ "Votrient (pazopanib) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Archived from the original on 2 February 2014. Retrieved 27 January 2014.
  3. ↑ ୩.୦ ୩.୧ ୩.୨ "CHMP Assessment Report: Votrient (pazopanib)" (PDF). European Medicines Agency. Archived (PDF) from the original on 9 October 2016. Retrieved 8 October 2016.
  4. ↑ ୪.୦ ୪.୧ ୪.୨ ୪.୩ ୪.୪ ୪.୫ BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 1039. ISBN 978-0857114105.
  5. ↑ "Votrient". Archived from the original on 22 October 2021. Retrieved 26 October 2021.
  6. ↑ "Pazopanib Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 26 October 2021.
"https://or.wikipedia.org/w/index.php?title=ବ୍ୟବହାରକାରୀ:Doc_James/Test&oldid=520474"ରୁ ଅଣାଯାଇଅଛି